Delivery Order SPE2DB22D1002-SPE2DB24FKZZ1
Award Date 3/28/24
Potential Completion Date 3/29/24
Potential Value $1.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a $7,169.35 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Lidocaine 5% patches. This delivery order falls under Amerisourcebergen Drug Corp's indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceuticals and medical...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564261498 - Lidocaine 5% Patch 30s. The contract has a ceiling value of $2,422.18 and a period of performance through April 15, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) previously awarded to Amerisourcebergen Drug Corp by DLA to provide a...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The $8,238.39 firm-fixed-price contract is for the delivery of 4,564,160,115 units of Lidocaine 5% Patch 30s, with a completion date of April 4, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Lidocaine 5% Patch 30s. The $1,130.91 contract has an ultimate completion date of April 8, 2024 and does not include any set-aside designation. This delivery order contract is associated with a larger $999,999,999.00 indefinite delivery contract (IDC) that DLA previously awarded to AmerisourceBergen...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $2,709.61 to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the provision of 4,564,340,251 units of Lidocaine 5% Patch 30s, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of Lidocaine 5% Patches. The contract, valued at $2,509.53, has a period of performance through June 28, 2024. It is a firm-fixed-price contract, without any set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (doing business as Amerisourcebergen), to provide 4563503771 - Lidocaine 5% Patch 30s. The order has a potential value of $3,409.20 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and this delivery order is issued under an indefinite delivery contract (IDC) with DLA valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,203.97 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4565698000 - Lidocaine 5% Patch 30s, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of medical commodities in support of military...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide 4564714526 - Lidocaine 5% Patch 30S. The $2,061.23 firm fixed-price contract has a completion date of May 28, 2024. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, to provide Lidocaine 5% patches. The total ceiling value of this delivery order is $2,688.82, with a period of performance through March 28, 2024. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which has a potential value of...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB24FKZZ1Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564108660 Lidocaine 5% Patch 30S. The contract, valued at $1,174.11, has a period of performance through March 29, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This delivery order does not have a set-aside designation.
Generated 6/27/24, 10:59 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 3/28/24 |